These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 22393533)

  • 1. Tumor endothelial cells.
    Dudley AC
    Cold Spring Harb Perspect Med; 2012 Mar; 2(3):a006536. PubMed ID: 22393533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new target for tumor therapy.
    Jain RK
    N Engl J Med; 2009 Jun; 360(25):2669-71. PubMed ID: 19535806
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms of ocular angiogenesis and its molecular mediators.
    Siemerink MJ; Augustin AJ; Schlingemann RO
    Dev Ophthalmol; 2010; 46():4-20. PubMed ID: 20703029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The multifaceted activity of VEGF in angiogenesis - Implications for therapy responses.
    Moens S; Goveia J; Stapor PC; Cantelmo AR; Carmeliet P
    Cytokine Growth Factor Rev; 2014 Aug; 25(4):473-82. PubMed ID: 25169850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular abnormalities of blood vessels as targets in cancer.
    Baluk P; Hashizume H; McDonald DM
    Curr Opin Genet Dev; 2005 Feb; 15(1):102-11. PubMed ID: 15661540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlling escape from angiogenesis inhibitors.
    Sennino B; McDonald DM
    Nat Rev Cancer; 2012 Oct; 12(10):699-709. PubMed ID: 23001349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normalization of the vasculature for treatment of cancer and other diseases.
    Goel S; Duda DG; Xu L; Munn LL; Boucher Y; Fukumura D; Jain RK
    Physiol Rev; 2011 Jul; 91(3):1071-121. PubMed ID: 21742796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of tumor microenvironment on cancer treatment and its modulation by direct and indirect antivascular strategies.
    Fokas E; McKenna WG; Muschel RJ
    Cancer Metastasis Rev; 2012 Dec; 31(3-4):823-42. PubMed ID: 22825313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding tumor endothelial cell abnormalities to develop ideal anti-angiogenic therapies.
    Hida K; Hida Y; Shindoh M
    Cancer Sci; 2008 Mar; 99(3):459-66. PubMed ID: 18167133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor receptors: expression and function in solid tumors.
    Wey JS; Stoeltzing O; Ellis LM
    Clin Adv Hematol Oncol; 2004 Jan; 2(1):37-45. PubMed ID: 16163158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond Angiogenesis: Exploiting Angiocrine Factors to Restrict Tumor Progression and Metastasis.
    Singhal M; Augustin HG
    Cancer Res; 2020 Feb; 80(4):659-662. PubMed ID: 31831463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vesicular trafficking mechanisms in endothelial cells as modulators of the tumor vasculature and targets of antiangiogenic therapies.
    Maes H; Olmeda D; Soengas MS; Agostinis P
    FEBS J; 2016 Jan; 283(1):25-38. PubMed ID: 26443003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing tumor angiogenesis: lessons from VEGF-resistant tumors and wounds.
    Cuevas I; Boudreau N
    Adv Cancer Res; 2009; 103():25-42. PubMed ID: 19854351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New aspects of vascular remodelling: the involvement of all vascular cell types.
    McGrath JC; Deighan C; Briones AM; Shafaroudi MM; McBride M; Adler J; Arribas SM; Vila E; Daly CJ
    Exp Physiol; 2005 Jul; 90(4):469-75. PubMed ID: 15894533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic and therapeutic aspects of angiogenesis.
    Potente M; Gerhardt H; Carmeliet P
    Cell; 2011 Sep; 146(6):873-87. PubMed ID: 21925313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial Progenitors in the Tumor Microenvironment.
    Testa U; Pelosi E; Castelli G
    Adv Exp Med Biol; 2020; 1263():85-115. PubMed ID: 32588325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can mosaic tumor vessels facilitate molecular diagnosis of cancer?
    Folkman J
    Proc Natl Acad Sci U S A; 2001 Jan; 98(2):398-400. PubMed ID: 11209044
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumor angiogenesis and vascular normalization: alternative therapeutic targets.
    Viallard C; Larrivée B
    Angiogenesis; 2017 Nov; 20(4):409-426. PubMed ID: 28660302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermedin: a novel regulator for vascular remodeling and tumor vessel normalization by regulating vascular endothelial-cadherin and extracellular signal-regulated kinase.
    Zhang W; Wang LJ; Xiao F; Wei Y; Ke W; Xin HB
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2721-32. PubMed ID: 22922959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiangiogenic therapy for cancer: current and emerging concepts.
    Jain RK
    Oncology (Williston Park); 2005 Apr; 19(4 Suppl 3):7-16. PubMed ID: 15934498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.